Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New bradykinin antagonists from Sanofi

Oct. 1, 1997

Cytokine inhibitors presented by SKB

Oct. 1, 1997

Celgene seeks FDA approval for clinical trials with thalidomide for autoimmune disorders

Sep. 29, 1997

Design and synthesis of COX-2 inhibitors related to indomethacin

Sep. 29, 1997

Tachykinin antagonists prepared at Pfizer

Sep. 29, 1997

Amgen seeks partner for inflammation R&D program

Sep. 23, 1997

Generic naproxen introduced in U.S.

Sep. 22, 1997

New NO donor-containing NSAID derivatives from NitroMed

Sep. 19, 1997

Fujisawa discloses new PDE IV/TNF inhibitors

Sep. 18, 1997

More on SE-205, a new MMP/TNF inhibitor from DuPont Merck

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...